Skip to main content
. 2014 Dec 2;93(28):e326. doi: 10.1097/MD.0000000000000326

TABLE 2.

Characteristics of RCTs of Vedolizumab Versus Placebo for Active IBD

graphic file with name medi-93-e326-g003.jpg